tiprankstipranks
Advertisement
Advertisement
Shattuck Labs Reports Promising Phase 1 Data for SL-325
PremiumCompany AnnouncementsShattuck Labs Reports Promising Phase 1 Data for SL-325
1M ago
Shattuck Labs TBA Spot Secondary; price range $4.00-$4.25
Premium
The Fly
Shattuck Labs TBA Spot Secondary; price range $4.00-$4.25
1M ago
Shattuck Labs announces common stock offering, no amount given
Premium
The Fly
Shattuck Labs announces common stock offering, no amount given
1M ago
Citi opens ‘upside 30-day catalyst watch’ on Shattuck into data
PremiumThe FlyCiti opens ‘upside 30-day catalyst watch’ on Shattuck into data
2M ago
Shattuck Labs upgraded to Buy from Neutral at Citi
Premium
The Fly
Shattuck Labs upgraded to Buy from Neutral at Citi
2M ago
Shattuck Labs Shareholders Approve Directors, Compensation, Governance Measures
Premium
Company Announcements
Shattuck Labs Shareholders Approve Directors, Compensation, Governance Measures
2M ago
Shattuck Labs initiated with an Overweight at Cantor Fitzgerald
PremiumThe FlyShattuck Labs initiated with an Overweight at Cantor Fitzgerald
3M ago
Shattuck Labs price target raised to $18 from $6 at H.C. Wainwright
Premium
The Fly
Shattuck Labs price target raised to $18 from $6 at H.C. Wainwright
3M ago
Shattuck Labs: Differentiated DR3 Antagonist SL-325 Positions Company for Upside in Emerging TL1A Immunology
Premium
Ratings
Shattuck Labs: Differentiated DR3 Antagonist SL-325 Positions Company for Upside in Emerging TL1A Immunology
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100